Figure 7.

Galangin inhibits human laryngeal carcinoma TU212 and HEP-2 cell proliferation via p38 and AKT/NF-κB suppression. (A) Signals of Ras, Raf and p-p38 were determined by western blot analysis. (B) The quantification of Ras, Raf and p-p38 in TU212 cells. (C) The quantification of Ras, Raf and p-p38 in HEP-2 cells. (D) Signals of PI3K, p-AKT and NF-κB were measured by western blot assays. The quantification of PI3K, p-AKT and NF-κB in (E) TU212, and (F) HEP-2 cells following immunoblot analysis. The analysis was conducted in triplicate, and the results are the mean ± SEM of three independent experiments. **P<0.01 and ***P<0.001 (compared to the control/Con).